Skip to Content
Webinar

Operationalizing 505(b)(2) Injectables in the Onco EMR

Date: July 9, 2026 | 2:30 PM

 

 

Join us for an upcoming discussion on operationalizing 505(b)(2) injectables in the oncology EMR featuring Venkat Varanasi (Avyxa) and Syed Zia Khan, PharmD, BCSCP (The START Center for Cancer Care).

What we’ll cover:

  • Explain how the onco EMR ingredient substitution workflow automatically selects the right 505(b)(2) product at ordering
  • Describe how EHR-embedded substitution eliminates manual pharmacy interventions and improves right-drug-on-day-one selection
  • Identify the five operational steps to set up a 505(b)(2) product in the onco EMR
  • Apply real-world data from The Start Center to build internal support for ingredient substitution
  • Recognize why proactive operationalization before a shortage occurs is a baseline requirement, not a contingency plan

For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.